S3870 is the authoritative medical code for Comparative genomic hybridization cgh microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability. This classification is used in medical billing and clinical recording to specify the clinical criteria for comparative genomic hybridization cgh microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability (HCPCS Level II S3870), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.
Official Registry Overview & Definition
Comparative genomic hybridization cgh microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability is a HCPCS Level II code S3870 for a Medicare-covered supply, service, or procedure. Short description: Cgh test developmental delay.
Nearest Codes in This Family
Official HCPCS Level II classifications closest to S3870 in its code family, with their registry titles.
- S3800 — Genetic testing for amyotrophic lateral sclerosis (als)
- S3840 — Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2
- S3841 — Genetic testing for retinoblastoma
- S3842 — Genetic testing for von hippel-lindau disease
- S3844 — Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness
- S3845 — Genetic testing for alpha-thalassemia
- S3846 — Genetic testing for hemoglobin e beta-thalassemia
- S3849 — Genetic testing for niemann-pick disease
- S3850 — Genetic testing for sickle cell anemia
- S3852 — Dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer's disease
View all 17 codes in the S3800 family